Evoq Remedies Limited

Services · Commercial Services & Supplies

BSE: 543500
₹1.53
▲ 0.07 (4.79%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
—/100
Weak
Valuation
—/100
Data unavailable
Momentum
43/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-65.9
Free Cash Flow
₹-0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (372 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
6.77
as of March 31, 2026
Industry median 2.48 (345 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 3 met
  • No Quality score is Strong (70 or more)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 1 met
  • No 1-year return beats the industry median

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
4.8%
Low 1.5300 · High 1.5300
1W return
6.3%
Low 1.3900 · High 1.5300
1M return
-7.8%
Low 1.3500 · High 1.6600
52W return
-80.9%
Low 1.3500 · High 1.9500
Lifetime High ₹23.7500 (March 30, 2022)
Lifetime Low ₹1.4000 (Sept. 21, 2026)

Full price history and technicals →

EMA & SMA

Bullish2
Bearish4
5D
1.5
10D
1.5
20D
1.7
50D
3.6
100D
6.0
200D
9.9

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1.53
Pivot
First resistance1.53
Second resistance1.53
Third resistance1.53
First support1.53
Second support1.53
Third support1.53
Day RSI28.0
Day MFI36.7
Day MACD-0.53
Day MACD signal-0.74

Beta

1M-0.88
3M-1.20
1Y-1.20
3Y0.32

Price change analysis

↓ -7.8%
Over 1 Month
LowHigh
1.351.66
↓ -80.9%
Over 3 Months
LowHigh
1.351.95
↓ -80.9%
Over 6 Months
LowHigh
1.351.95
↓ -80.9%
Over 1 Year
LowHigh
1.351.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 315 in Commercial Services & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter0.02%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 11.21% to 0.02% in Mar 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
15 Jun 2026 SURYA PRAKASH JETHLIA Bulk Sell 164,000 2.6400 BSE
11 Dec 2025 JANAKI BOOPALAN RAJESWARI Bulk Sell 128,000 2.6200 BSE
8 Dec 2025 NIRAJ RAJNIKANT SHAH Bulk Sell 176,000 2.7900 BSE
28 Nov 2025 NIRAJ RAJNIKANT SHAH Bulk Sell 144,000 3.0500 BSE
26 Nov 2025 NIRAJ RAJNIKANT SHAH Bulk Sell 144,000 3.1100 BSE
25 Nov 2025 PANCHAL Bulk Sell 184,000 3.2300 BSE
20 Nov 2025 JITEN KUMAR BISWAS Bulk Sell 140,000 3.7400 BSE
17 Nov 2025 NILESH M SUHAGIYA Bulk Buy 152,000 3.9400 BSE
12 Nov 2025 JITEN KUMAR BISWAS Bulk Sell 136,000 3.9200 BSE
12 Nov 2025 NILESH M SUHAGIYA Bulk Buy 296,000 3.9200 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Company Update Evoq Remedies Ltd - 543500 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Approval Of Extension Of Time For Holding 16Th Annual General Meeting ('AGM') For The Financial Year Ended 31St March 2026
30 Sep 2026 Insider Trading / SAST Evoq Remedies Ltd - 543500 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (28.0) -- a technical rebound zone

Threats

  • Down 80.9% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Evoq Remedies Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.